Oral tetracycline antibiotic (anti-acne)
Pregnancy: Avoid in second and third trimester. Use topical alternatives in pregnancy.
Lymecycline 408mg (Acne)
Brand names: Tetralysal 300
Adult dose
Dose: 408 mg once daily
Route: Oral (may be taken with or without food — better GI tolerability than older tetracyclines)
Frequency: Once daily
Max: 408 mg/day
Licensed in the UK specifically for acne vulgaris. Lymecycline 408 mg = equivalent to approximately 300 mg tetracycline base. Minimum course 8 weeks; continue for at least 3–6 months for acne. Combine with topical benzoyl peroxide to limit antibiotic resistance.
Paediatric dose
Route: Oral
Frequency: Once daily
Max: Not recommended in children <12 years
Contraindicated under 12 years (dental staining, bone development). Adolescents ≥12 years: adult dose 408 mg OD.
Dose adjustments
Renal
Use with caution in renal impairment; lymecycline is renally excreted — avoid if eGFR significantly reduced.
Hepatic
Use with caution in hepatic impairment.
Clinical pearls
- UK-licensed tetracycline specifically for acne — alternative to doxycycline with once-daily dosing and improved GI tolerability
- Combine with topical benzoyl peroxide to reduce risk of antibiotic-resistant C. acnes — BAD and NICE guidance
- Generally better tolerated than oxytetracycline (twice-daily, food restrictions) — preferred oral tetracycline in many BAD guidelines
- Allow minimum 3 months before assessing response; up to 6 months for full effect
- No food restrictions unlike oxytetracycline — improves adherence
Contraindications
- Children under 12 years
- Pregnancy (second and third trimester)
- Breastfeeding
- Concurrent isotretinoin or acitretin (pseudotumour cerebri)
- Hypersensitivity to tetracyclines
Side effects
- GI upset (generally better tolerated than older tetracyclines)
- Photosensitivity
- Oesophageal irritation (less common than doxycycline)
- Vaginal candidiasis (prolonged use)
- Pseudotumour cerebri (with concurrent retinoids)
Interactions
- Antacids (iron, calcium, magnesium, aluminium) — separate by 2 hours
- Isotretinoin / acitretin — contraindicated
- Warfarin — monitor INR (possible enhanced anticoagulation)
Monitoring
- Acne response at 3 months
- Photosensitivity reactions
- Symptoms of raised ICP
Reference: BNFc; BNF; BAD Acne Guidelines 2021; NICE CG184. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
- Acne Severity Classification (IGA Scale) · Acne
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Revised Original International Autoimmune Hepatitis Score (IAIHG) · Autoimmune Liver Disease
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- FeverPAIN Score for Strep Throat · Throat
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD